Navigation Links
Weizmann Institute solar technology to convert greenhouse gas into fuel
Date:6/7/2012

An Israeli-Australian venture will use solar technology developed at the Weizmann Institute of Science to reduce carbon dioxide emissions from the burning of brown coal. The venture has been recently launched in Israel by NewCO2Fuels Ltd., a subsidiary of the Australian company Greenearth Energy Ltd., which has acquired an exclusive worldwide license for the solar technology from Yeda, the Weizmann Institute's technology transfer arm.

The Weizmann technology makes use of concentrated solar energy to dissociate carbon dioxide (CO2) to carbon monoxide (CO) and oxygen (O2). This method, developed at the Weizmann Institute by Prof. Jacob Karni, also makes it possible to dissociate water (H2O) to hydrogen (H2) and oxygen (O2) at the same time it dismantles the CO2.

Carbon monoxide (CO), or its mixture with hydrogen called Syngas, can then be used as gaseous fuel, for example, in power plants, or converted to liquid fuel such as methanol, which can be stored, transported or used to power motor vehicles.

The method has proved successful in laboratory trials. NewCO2Fuels Ltd. is now building a solar reactor for the conversion of CO2 on an industrial scale. Part of the development is being performed in collaboration with the Canadian Institute for the Energies and Applied Research at the Weizmann Institute of Science.

Greenearth Energy expects the new Israeli-Australian venture to help harness the vast brown coal resources in the State of Victoria in south-eastern Australia, whose use has been limited until now by the high CO2 emission content from this type of coal. The possibility of converting CO2 to fuel in a clean and efficient manner will turn brown coal into a source of environmentally friendly fuel.


'/>"/>
Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Esther B. OKeeffe Foundation gives $2 million to the Scripps Research Institute
2. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
3. CUNY Energy Institute battery system could reduce buildings electric bills
4. TGen leads new National Institutes of Health study of brain tumors
5. Merkin Family Foundation to fund next generation of Broad Institute scientists
6. NJIT, Chinas Bengbu Glass Institute sign agreement for R&D, training
7. Scripps Research Institute scientists develop antidote for cocaine overdose
8. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
9. Cary Institute Hydrofracking Forum
10. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
11. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
Breaking Biology Technology: